[29P-am] Clinical Pharmacy

[29P-am400S] A comparative safety study of antiplatelet monotherapy with aspirin and ADP receptor P2Y12 inhibitor versus combination therapy in patients undergoing coil embolization

○Yuuri Nakamura¹, Shinobu Imai², Hiroshi Magara¹, Takuaki Tani², Anna Kiyomi¹, Munetoshi Sugiura¹, Kiyohide Fushimi³ (1. Department of Drug Safety and Risk Management,School of Pharmacy,Tokyo University of Pharmacy and Life Sciences, 2. Department of Pharmacoepidemiology, Showa University Graduate School of Pharmacy, 3. Department of Health Policy and Informatics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University)